Christina Karamboulas - Princess Margaret Cancer Centre - Research Associate

Christina Karamboulas

Princess Margaret Cancer Centre

Research Associate

Toronto, Ontario | Canada

Main Specialties: Biology, Oncology

Additional Specialties: head and neck squamous cell carcinoma

Christina Karamboulas - Princess Margaret Cancer Centre - Research Associate

Christina Karamboulas

Introduction

Primary Affiliation: Princess Margaret Cancer Centre - Toronto, Ontario , Canada

Specialties:

Additional Specialties:

Research Interests:

Education

May 2006
University of Western Ontario
PhD
Biochemistry

Publications

11Publications

285Reads

1Profile Views

Patient-derived xenografts: a promising resource for preclinical cancer research.

Mol Cell Oncol 2019 8;6(1):1558684. Epub 2019 Jan 8.

Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/23723556.2018.1558684DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370391PMC
January 2019
1 Read

Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma.

Cell Rep 2018 10;25(5):1318-1331.e4

Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2018.10.004DOI Listing
October 2018
3 Reads
7.207 Impact Factor

CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma.

Oncotarget 2014 Aug;5(16):6854-66

Division of Head and Neck Surgery, Department of Otolaryngology, Stanford University School of Medicine, Stanford, CA. Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA. Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196168PMC
http://dx.doi.org/10.18632/oncotarget.2269DOI Listing
August 2014
66 Reads
6.359 Impact Factor

Developmental signaling pathways in cancer stem cells of solid tumors.

Biochim Biophys Acta 2013 Feb 27;1830(2):2481-95. Epub 2012 Nov 27.

Ontario Cancer Institute, Campbell Family Cancer Research Institute, University Health Network, Toronto, Ontario, Canada M5G 1L7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbagen.2012.11.008DOI Listing
February 2013
57 Reads

Gli2 and MEF2C activate each other's expression and function synergistically during cardiomyogenesis in vitro.

Nucleic Acids Res 2012 Apr 22;40(8):3329-47. Epub 2011 Dec 22.

Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkr1232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333882PMC
April 2012
3 Reads
9.112 Impact Factor

Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis.

J Cell Sci 2006 Oct 26;119(Pt 20):4315-21. Epub 2006 Sep 26.

Department of Biochemistry, Medical Sciences Building, University of Western Ontario, London, Ontario, N6A 5C1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/jcs.03186DOI Listing
October 2006
8 Reads
5.432 Impact Factor

HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage.

J Cell Sci 2006 Oct;119(Pt 20):4305-14

Department of Biochemistry, Medical Sciences Building, University of Western Ontario, London, Ontario, N6A 5C1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/jcs.03185DOI Listing
October 2006
10 Reads
5.432 Impact Factor